Considerations for the pharmacological treatment of diabetes in older adults
Dealing with side effects frequently translates to dose changes, extra fluids, or holding medication prior to surgery
Gorban, P
Cell Metab 10:167177 Lenhard JM, Croom DK, Minnick DT (2004) Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments
Among these nanosytsems, polymer-based carriers, including polycaprolactone (PCL), polyethylene glycol (PEG), and chitosan, PLGA, offered an attractive biodegradable platform for encapsulating both synthetic drugs and bioactive natural compounds 29
On eligibility, I used the clinically warranted threshold of BMI 27 with one weight-related comorbidity as used by clinical trials, and the US, Canadian, and European approved label